Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (697)	11/6/1997 10:13:00 AM
From: TradeOfTheDay	Respond to of 7041

as you can tell by the price of the stock , we're worried...... very worried about it <g> have a great day !

To: Tokyo VD who wrote (697)	11/6/1997 2:24:00 PM
From: Bradpalm1	Read Replies (1) \| Respond to of 7041

Toyko VD, Is it true that both Cruttendon Roth and Genesis Merchant turned down banking deals with Zonagen last year? Why would THESE companies (of all companies) turn down Zonagen? Sounds a little fishy to me. Bradpalm1

To: Tokyo VD who wrote (697)	11/6/1997 3:02:00 PM
From: Dauntless	Read Replies (1) \| Respond to of 7041

I can think of several prople who have read the patents. By all accounts, Zonagen has been actively engaged in negotiations with several big pharma companies for the distribution rights to this drug. Isn't it logical to assume that these potential partners have considered the strength of these patent(s). I, for one, have no problem admitting that they have a much better understanding of these matters than I do. I'd also guess that their knowledge probably exceeds even yours. Now, if the patents haven't killed their interest, why should dampen ours?? Get real, please.